This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert M. Post, MD; Ed Fink, MD; William T. Carpenter, Jr, MD; Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1975;32(8):1063-1069.

Abstract
The metabolites of serotonin, dopamine, and norepinephrine, 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxy-phenylethylene glycol (MHPG), respectively, were studied in cerebrospinal fluid of patients with acute schizophrenia. Base line levels of these metabolites were not significantly different from those in normal, neurological, and affectively ill controls. Accumulations of 5HIAA and HVA following probenecid administration, which provide a measure of serotonin and dopamine turnover, were also not significantly different in patients with acute schizophrenia and affective illness.

After patients had recovered from their acute schizophrenic illness, HVA accumulations were significantly reduced. We discuss results in relation to amine hypotheses of schizophrenia and the suggestion that altered dopamine metabolism may reflect a biological change predisposing to acute schizophrenia.

Author Affiliations
From the Adult Psychiatry Branch (Drs. Post, Fink, and Carpenter) and the Laboratory of Clinical Science (Dr. Goodwin), National Institute of Mental Health, Bethesda, Md. Dr. Fink is now with Butler Hospital, Providence, RI.

Footnotes
Accepted for publication March 25, 1975.

Reprint requests to the Section on Psychobiology, Adult Psychiatry Branch, National Institute of Mental Health, Bldg 10, Rm 3S 239, 9000 Rockville Pike, Bethesda, MD 20014 (Dr. Post).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

PET Study of [18F]6-Fluoro-L-Dopa Uptake in Neuroleptic- and Mood-Stabilizer-Naive First-Episode Nonpsychotic Mania: Effects of Treatment With Divalproex Sodium
Yatham et al.
Am. J. Psychiatry 2002;159:768-774.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis: Implications for Regional Brain Dysfunction in Schizophrenia
Pickar et al.
Arch Gen Psychiatry 1990;47:641-648.
ABSTRACT  

Dopamine Metabolism and Disposition in Schizophrenic Patients: Studies Using Debrisoquin
Maas et al.
Arch Gen Psychiatry 1988;45:553-559.
ABSTRACT  

Noradrenergic Function in Schizophrenia
Glazer et al.
Arch Gen Psychiatry 1987;44:898-904.
ABSTRACT  

Growth Hormone Response to Apomorphine
Ferrier et al.
Arch Gen Psychiatry 1987;44:93-93.
ABSTRACT  

Relation of Clinical Symptoms to Apomorphine-Stimulated Growth Hormone Release in Mood-Incongruent Psychotic Patients
Zemlan et al.
Arch Gen Psychiatry 1986;43:1162-1167.
ABSTRACT  

Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
van Kammen et al.
Arch Gen Psychiatry 1986;43:978-983.
ABSTRACT  

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy
van Kammen et al.
Science 1983;220:974-977.
ABSTRACT  

Increased Brain Dopamine and Dopamine Receptors in Schizophrenia
Mackay et al.
Arch Gen Psychiatry 1982;39:991-997.
ABSTRACT  

Aberrant Monoamine Metabolite Levels in CSF and Family History of Schizophrenia: Their Relationships in Schizophrenic Patients
Sedvall and Wode-Helgodt
Arch Gen Psychiatry 1980;37:1113-1116.
ABSTRACT  

Schizophrenia: elevated cerebrospinal fluid norepinephrine
Lake et al.
Science 1980;207:331-333.
ABSTRACT  

Probenecid-Induced Norepinephrine Elevations in Plasma and CSF
Lake et al.
Arch Gen Psychiatry 1978;35:237-240.
ABSTRACT  

Dopamine Excretion and Vulnerability to Drug-Induced Parkinsonism: Schizophrenic Patients
Crowley et al.
Arch Gen Psychiatry 1978;35:97-104.
ABSTRACT  

Increased Norepinephrine Levels and Decreased Dopamine-{beta}-Hydroxylase Activity in Primary Autism
Lake et al.
Arch Gen Psychiatry 1977;34:553-556.
ABSTRACT